Wntresearch AB logo

Wntresearch AB (WNT)

Delisted
XSTO XSTO
kr
kr
94.83M Market Cap
- P/E Ratio
- Div Yield
- Volume
- Eps
kr
Previous Close
Day Range
0 0
Year Range
0 0
Want to track WNT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

This company has been delisted from its primary exchange and is no longer publicly traded.
As a result, real-time price data, dividend updates, and corporate disclosures may no longer be available.

WNT Chart

Wntresearch AB (WNT) FAQ

What does "Delisted" mean?

Wntresearch AB has been removed from the exchange and is no longer publicly traded.

What was the last recorded dividend?

No dividend payments were recorded prior to delisting.

How long did the company pay dividends?

The company did not have a dividend payment history.

Were there any stock splits?

The last recorded stock split occurred on May 28, 2024 with a ratio of 1:100.

What was the last known trading price?

Final trading price data is not available.

Wntresearch AB Profile

- Industry
- Sector
- CEO
XSTO Exchange
- ISIN
Sweden Country
2 Employees
- Last Dividend
- Last Split
- IPO Date
WntResearch AB, a biotech company, develops therapies to prevent the metastatic process. The company develops Foxy-5, a peptide, which is in Phase II clinical trials that reduced the risk of metastasis in patients with colon cancer. It is also developing Box-5, a WNT5A antagonist for the treatment of malignant melanoma, and pancreatic and gastric cancer. The company was incorporated in 2007 and is based in Lund, Sweden.

Contact Information

Address: Stora Södergatan 15
Phone: -